ASTRANA HEALTH ($ASTH) posted quarterly earnings results for Q2 2026 on Thursday, August 6th. The company reported earnings of $0.40 per share, beating estimates of $0.34 by $0.06. The company also reported revenue of $972,520,000, missing estimates of $1,005,430,626 by $-32,910,626.
Stock price change since market close: -1.26%
You can see Quiver Quantitative's $ASTH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ASTRANA HEALTH Hedge Fund Activity
We have seen 103 institutional investors add shares of ASTRANA HEALTH stock to their portfolio, and 70 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- 683 CAPITAL MANAGEMENT, LLC added 700,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $17,164,000
- FMR LLC removed 653,684 shares (-61.1%) from their portfolio in Q1 2026, for an estimated $16,028,331
- WELLINGTON MANAGEMENT GROUP LLP added 602,971 shares (+81.6%) to their portfolio in Q1 2026, for an estimated $14,784,848
- DIMENSIONAL FUND ADVISORS LP added 152,267 shares (+12.5%) to their portfolio in Q1 2026, for an estimated $3,733,586
- UBS GROUP AG added 125,826 shares (+71.5%) to their portfolio in Q1 2026, for an estimated $3,085,253
- DIAMOND HILL CAPITAL MANAGEMENT INC added 111,308 shares (+25.7%) to their portfolio in Q1 2026, for an estimated $2,729,272
- MORGAN STANLEY removed 95,022 shares (-21.9%) from their portfolio in Q1 2026, for an estimated $2,329,939
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ASTRANA HEALTH Analyst Ratings
Wall Street analysts have issued reports on $ASTH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 06/02/2026
- Needham issued a "Buy" rating on 05/08/2026
To track analyst ratings and price targets for ASTRANA HEALTH, check out Quiver Quantitative's $ASTH forecast page.
ASTRANA HEALTH Price Targets
Multiple analysts have issued price targets for $ASTH recently. We have seen 6 analysts offer price targets for $ASTH in the last 6 months, with a median target of $46.0.
Here are some recent targets:
- David Larsen from BTIG set a target price of $50.0 on 06/02/2026
- Andrew Mok from Barclays set a target price of $50.0 on 05/26/2026
- Jailendra Singh from Truist Securities set a target price of $47.0 on 05/14/2026
- Ryan Langston from TD Cowen set a target price of $45.0 on 05/12/2026
- Matthew Shea from Needham set a target price of $41.0 on 05/08/2026
- Michael Ha from Baird set a target price of $40.0 on 04/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
